FIBROGEN INC (FGEN)
US31572Q8087 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 63.40M | 135.80M | 111.40M | 88.00M | 40.70M | |||
| Cash Equivalents | 50.29M | 19.90M | 59.80M | 590.30M | 85.60M | |||
| Marketable Securities | 121.90M | 266.30M | 234.00M | 8.10M | 407.50M | |||
| Receivables | 41.05M | 16.30M | 25.40M | 41.90M | 153.70M | |||
| Inventories | 41.56M | 40.40M | 31.00M | 16.50M | 6.90M | |||
| Other Current Assets | 13.36M | 14.10M | 12.50M | 10.20M | 8.20M | |||
| Total Current Assets | 331.56M | 492.80M | 474.10M | 755.10M | 702.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 81.37M | 100.90M | 120.20M | 65.30M | 84.30M | |||
| Investments And Advances | 5.29M | 9.40M | 171.60M | 3.00M | 61.10M | |||
| Other Non-Current Assets | 5.31M | 6.90M | 8.00M | 3.50M | 9.50M | |||
| Total Non-Current Assets | 91.97M | 117.30M | 299.70M | 71.70M | 154.90M | |||
| TOTAL ASSETS | 423.53M | 610.10M | 773.80M | 826.80M | 857.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 40.00K | 0.00 | 0.00 | 12.30M | 12.40M | |||
| Accrued Expenses | 186.93M | 229.60M | 180.40M | 104.40M | 83.80M | |||
| Accounts Payable | 17.96M | 30.80M | 26.10M | 24.80M | 6.10M | |||
| Other Current Liabilities | 12.74M | 13.10M | 19.00M | 21.70M | 500.00K | |||
| Total Current Liabilities | 217.67M | 273.60M | 225.50M | 163.20M | 102.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 89.80M | 17.10M | 17.60M | 44.10M | 55.50M | |||
| Deferred Taxes/Income | N/A | N/A | 9.20M | 8.70M | N/A | |||
| Other Non-Current Liabilities | 278.26M | 321.00M | 292.40M | 169.40M | 163.70M | |||
| Total Non-Current Liabilities | 410.03M | 357.90M | 339.20M | 241.50M | 238.60M | |||
| TOTAL LIABILITIES | 627.70M | 631.50M | 564.70M | 404.70M | 341.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.84B | -1.56B | -1.26B | -974.00M | -784.70M | |||
| Additional Paid In Capital | 1.64B | 1.54B | 1.48B | 1.40B | 1.30B | |||
| Minority Interest | 41.97M | 20.00M | 20.00M | 19.30M | 19.30M | |||
| Common Shares | 988.00K | 900.00K | 900.00K | 900.00K | 900.00K | |||
| Other Shareholders' Equity | -6.88M | -5.70M | -4.20M | -4.50M | -700.00K | |||
| Shares Outstanding | 98.77M | 94.20M | 92.90M | 91.40M | 87.70M | |||
| Tangible Book Value per Share | -2.07 | -0.23 | 2.25 | 4.62 | 5.88 | |||
| Total Shareholders' Equity | -204.17M | -21.40M | 209.10M | 422.20M | 516.10M | |||
| TOTAL LIABILITIES AND EQUITY | 423.53M | 610.10M | 773.80M | 826.80M | 857.40M | |||
| Statistics | ||||||||
| Debt/Equity | -0.44 | -0.80 | 0.08 | 0.10 | 0.11 | |||
| Current Ratio | 1.52 | 1.80 | 2.10 | 4.63 | 6.84 | |||
| Return On Assets (ROA) | -67.11% | -48.14% | -37.48% | -22.90% | -8.98% | |||
| Return On Equity (ROE) | N/A | N/A | -138.69% | -44.84% | -14.92% | |||
All data in USD